Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Correction: Comparing Efficacy and Safety of P013, a Proposed Pertuzumab Biosimilar, With the Reference Product in Her2-Positive Breast Cancer Patients: A Randomized, Phase Iii, Equivalency Clinical Trial (Bmc Cancer, (2022), 22, 1, (960), 10.1186/S12885-022-09895-5)
Valiollah Mehrzad
Valiollah Mehrzad

Associate Professor of Hematology &

Oncology

Department of Internal Medicine, School of Medicine

Cancer Prevention Research Center

Seyyed Al-Shohada Hospital

Isfahan University of Medical Sciences

All Documents
37. Marital Satisfaction and Mental Health Status in Patients With Breast Cancer, Journal of Research in Medical Sciences (2012)